Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

9.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebral Proteomic Changes in the rTg-D Rat Model of Cerebral Amyloid Angiopathy Type-2 With Cortical Microhemorrhages and Cognitive Impairments.

Neuroscience insights·2024
Same author

Constitutive activation and oncogenicity are mediated by loss of helical structure at the cytosolic boundary of thrombopoietin receptor mutant dimers.

eLife·2023
Same author

Impact of Aβ40 and Aβ42 Fibrils on the Transcriptome of Primary Astrocytes and Microglia.

Biomedicines·2022
Same author

Distinct Brain Proteomic Signatures in Cerebral Small Vessel Disease Rat Models of Hypertension and Cerebral Amyloid Angiopathy.

Journal of neuropathology and experimental neurology·2022
Same author

Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.

Biochemistry·2022
Same author

Distinct brain regional proteome changes in the rTg-DI rat model of cerebral amyloid angiopathy.

Journal of neurochemistry·2021

Related Experiment Video

Updated: Jun 3, 2025

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.1K

Aβ40 Fibril Assembly on Human Cerebral Smooth Muscle Cells Impairs Cell Viability.

Brandon Irizarry1, Judianne Davis2, Jitika Rajpoot1

  • 1Center for Structural Biology, Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York 11794-5215, United States.

Biochemistry
|January 7, 2025
PubMed
Summary

Cerebral amyloid angiopathy (CAA) involves amyloid-β (Aβ) peptide buildup in brain vessels. This study shows fibrillar Aβ seeds promote new amyloid formation on smooth muscle cells, causing cell death and advancing disease.

More Related Videos

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
10:36

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Published on: June 20, 2017

8.5K
Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
06:23

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

7.9K

Related Experiment Videos

Last Updated: Jun 3, 2025

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

9.1K
In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption
10:36

In Vitro Assays to Assess Blood-brain Barrier Mesh-like Vessel Formation and Disruption

Published on: June 20, 2017

8.5K
Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons
06:23

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

7.9K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Cerebral amyloid angiopathy (CAA) is linked to brain hemorrhaging and cognitive decline in Alzheimer's disease (AD) and vascular cognitive impairment and dementia (VCID).
  • Familial mutations in amyloid-β (Aβ) peptide at positions 22 and 23 accelerate CAA pathology.
  • Human cerebral smooth muscle (HCSM) cells are key sites for amyloid deposition in cerebral blood vessels.

Purpose of the Study:

  • To investigate the impact of fibrillar Aβ peptides on HCSM cell viability.
  • To compare the effects of familial mutant Aβ40 (Dutch) with wild-type Aβ40 and Aβ42.

Main Methods:

  • Primary cultures of HCSM cells were treated with monomeric and fibrillar forms of Aβ peptides.
  • Cell viability was assessed after exposure to different Aβ variants and fibril seeds.
  • Intrathecal administration of Aβ40-Dutch fibrillar seeds was performed in a transgenic rat model of CAA.

Main Results:

  • Monomeric Aβ40-Dutch and Aβ42-WT significantly reduced HCSM cell viability, while Aβ40-WT was less toxic.
  • Aβ fibrils from sporadic or familial CAA did not significantly decrease HCSM cell viability upon direct binding.
  • Coincubation of Aβ40-WT monomers with sporadic CAA fibrils significantly reduced cell viability and increased cell surface fibril formation.
  • Intrathecal Aβ40-Dutch seeds promoted fibrillar amyloid accumulation in meningeal vessel smooth muscle in rats.

Conclusions:

  • Fibrillar Aβ seeds can propagate new amyloid fibril expansion on cerebral vascular smooth muscle.
  • This process leads to membrane disruption and HCSM cell death.
  • The findings suggest a mechanism for CAA progression involving seed-mediated amyloid expansion and vascular damage.